A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream"
Clinical trial NCT03954444 · COMPLETED
Trial details
- NCT number
- NCT03954444
- Sponsor
- Actavis Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-15
- Primary completion
- 2020-01-07
- Enrollment
- 1105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.